{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:58Z","timestamp":1788279418762,"version":"build-2803163510"},"reference-count":24,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":228,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study examined the relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients. The aim was to ascertain whether elevated free thyroxine in treated patients suggests overmedication or is essential for maintaining appropriate free triiodothyronine levels, guiding improved monitoring practices during therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 3,020 free thyroxine measurements from 1,409 patients between July 2021 and March 2024. Patients with thyrotropin receptor antibodies or treated with antithyroid drugs such as thiamazole, propylthiouracil, and potassium iodide were excluded. Measurements were performed using the Elecsys FT4 III immunoassay, and statistical comparisons were made between levothyroxine-treated and untreated groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Levothyroxine-treated patients showed significantly higher median free thyroxine levels (17.9 pmol\/L, interquartile range (IQR): 15.6\u201320.1) than untreated patients (16.2 pmol\/L, IQR: 14.5\u201317.9, P &amp;lt; 0.0001). In addition, the free triiodothyronine\/free thyroxine ratio was significantly lower in levothyroxine-treated patients (0.24, IQR: 0.20\u20130.29) than in untreated patients (0.28, IQR: 0.25\u20130.32, P &amp;lt; 0.0001). Free thyroxine levels increased with levothyroxine dosage, whereas the free triiodothyronine\/free thyroxine ratio decreased. Although thyroid-stimulating hormone levels did not differ significantly between the groups, higher levothyroxine doses were associated with mild suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings emphasize the importance of higher free thyroxine levels for maintaining adequate free triiodothyronine in levothyroxine-treated patients, underscoring the need to monitor free thyroxine, free triiodothyronine, and their ratio during therapy to optimize treatment outcomes. In addition, clinicians should recognize that higher levothyroxine doses may elevate free thyroxine levels beyond the reference range.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-24-0388","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:30:15Z","timestamp":1751880615000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-507X","authenticated-orcid":true,"given":"Toshihiko","family":"Kasahara","sequence":"first","affiliation":[{"name":"Kasahara Clinic , , ,","place":["Chuo-ku, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"2026070713014777500_bib1","first-page":"128","volume-title":"Werner & Ingbar\u2019s The Thyroid: A Fundamental and Clinical Text","author":"Yen","edition":"11th edn"},{"key":"2026070713014777500_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1507\/endocrj.EJ19-0094","article-title":"Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients","volume":"66","author":"Ito","year":"2019","journal-title":"Endocr J"},{"key":"2026070713014777500_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1089\/thy.2019.0135","article-title":"Serum thyroid hormone balance in levothyroxine monotherapy-treated patients with atrophic thyroid after radioiodine treatment for Graves\u2019 disease","volume":"29","author":"Ito","year":"2019","journal-title":"Thyroid"},{"key":"2026070713014777500_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1507\/endocrj.EJ19-0063","article-title":"The association between thyroid hormone balance and thyroid volume in patients with Hashimoto thyroiditis","volume":"66","author":"Kawasaki","year":"2019","journal-title":"Endocr J"},{"key":"2026070713014777500_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1507\/endocrj.EJ20-0542","article-title":"Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism","volume":"68","author":"Takahashi","year":"2021","journal-title":"Endocr J"},{"key":"2026070713014777500_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"2026070713014777500_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.31128\/AJGP-10-20-5693","article-title":"Thyroid disease: using diagnostic tools effectively","volume":"50","author":"Croker","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"2026070713014777500_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.1989.00390030032006","article-title":"Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients","volume":"149","author":"de los Santos","year":"1989","journal-title":"Arch Intern Med"},{"key":"2026070713014777500_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12020-022-03098-5","article-title":"How to approach clinically discordant FT4 results when changing testing platforms: real-world evidence","volume":"77","author":"Giovanella","year":"2022","journal-title":"Endocrine"},{"key":"2026070713014777500_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13044-022-00127-3","article-title":"Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study","volume":"15","author":"Ito","year":"2022","journal-title":"Thyroid Res"},{"key":"2026070713014777500_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/thy.2016.0426","article-title":"Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy","volume":"27","author":"Ito","year":"2017","journal-title":"Thyroid"},{"key":"2026070713014777500_bib12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/mend.14.11.0558","article-title":"Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation","volume":"14","author":"Gereben","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2026070713014777500_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI77588","article-title":"Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine","volume":"125","author":"Werneck de Castro","year":"2015","journal-title":"J Clin Investig"},{"key":"2026070713014777500_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000447967","article-title":"Relational stability of thyroid hormones in euthyroid subjects and patients with autoimmune thyroid disease","volume":"5","author":"Hoermann","year":"2016","journal-title":"Eur Thyroid J"},{"key":"2026070713014777500_bib15","first-page":"3257","article-title":"Changes in thyroid volume in response to radioactive iodine for Graves\u2019 hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome","volume":"81","author":"Murakami","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713014777500_bib16","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team"},{"key":"2026070713014777500_bib17","article-title":"PMCMRplus: calculate pairwise multiple comparisons of mean rank sums extended","author":"Pohlert","year":"2024"},{"key":"2026070713014777500_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Software"},{"key":"2026070713014777500_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11154-021-09691-9","article-title":"Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults","volume":"23","author":"Caron","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"2026070713014777500_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1515\/cclm-2020-1696","article-title":"Global FT4 immunoassay standardization: an expert opinion review","volume":"59","author":"Kratzsch","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"2026070713014777500_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/thy.2015.0085","article-title":"An inverse relationship between weight and free thyroxine during early gestation among women treated for hypothyroidism","volume":"25","author":"Haddow","year":"2015","journal-title":"Thyroid"},{"key":"2026070713014777500_bib22","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/jc.2011-3399","article-title":"Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?","volume":"97","author":"Biondi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713014777500_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13044-018-0045-x","article-title":"Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance","volume":"11","author":"Dayan","year":"2018","journal-title":"Thyroid Res"},{"key":"2026070713014777500_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/4\/ETJ-24-0388.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/4\/ETJ-24-0388.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0388\/35057\/etj-24-0388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0388\/35057\/etj-24-0388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:31:45Z","timestamp":1783445505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/4\/e240388\/4754\/The-relationship-between-levothyroxine-dosage-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-24-0388","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"article-number":"e240388"}}